Clinical Trials Logo

Clinical Trial Summary

Hospital-Acquired Influenza (HAI) is closely linked to the intensity of influenza in the community. HAI is associated with significant morbidity, mortality and extra costs due to prolonged hospital stay. The incidence of laboratory confirmed HAI has been reported rarely. The proportion of HAI among influenza cases was 11.38% (95% Confidence Interval: 5.19%-19.55%) in a meta-analysis of 14 studies. In France, a prospective surveillance study of adults with Influenza-Like Illness (ILI) over 11 years, reported that 35.6% of the influenza cases diagnosed at hospital were hospital-acquired. HAI is transmitted via respiratory droplets and by hand contacts. The spread is facilitated by Health Care Professionals (HCPs), patients and visitors. Prevention and control of HAI is of upmost importance to preserve patient safety and limit the related economic costs. While vaccination of HCPs has been shown to contribute to the reduction of HAI, less is known on the impact of patient vaccination on the risk of HAI during hospitalization. The aim of this study is to describe the hospital-acquired influenza in a french university hospital.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05712759
Study type Observational
Source Hospices Civils de Lyon
Contact Philippe VANHEMS, MD
Phone 0472110719
Email philippe.vanhems@chu-lyon.fr
Status Not yet recruiting
Phase
Start date February 1, 2025
Completion date June 1, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT06178822 - Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed NCT05041764 - RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
Recruiting NCT03818334 - Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies Phase 2/Phase 3
Completed NCT04637867 - COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Completed NCT05069623 - A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers Phase 1/Phase 2
Recruiting NCT04386460 - Covid-19 and Prevention of Malnutrition After Confinement by Dentists
Completed NCT04290780 - COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
Completed NCT04327180 - PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
Recruiting NCT04438629 - Evaluation of Immune Response in COVID-19 Patients
Active, not recruiting NCT05874713 - Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults Phase 2
Completed NCT03163628 - biomArkers to differeNtiate bacTerial From vIral iNfEctions N/A
Completed NCT04924842 - COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
Completed NCT04354155 - COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial Phase 2
Recruiting NCT05875961 - Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults Phase 1
Recruiting NCT06379061 - Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
Active, not recruiting NCT04481529 - COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
Recruiting NCT05090319 - Micro-hematology Analyzer for Viral/Bacterial Description
Not yet recruiting NCT04887233 - Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19) N/A